Clinimed Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-12-2024
- Paid Up Capital ₹ 0.30 M
as on 30-12-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.71 M
as on 30-12-2024
- Revenue 351.12%
(FY 2022)
- Profit 19581.88%
(FY 2022)
- Ebitda 2161.07%
(FY 2022)
- Net Worth 1231.86%
(FY 2022)
- Total Assets 294.34%
(FY 2022)
About Clinimed Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹4.71 M.
Arindam Ray, Arpan Bhattacharya, Adreesh Chattopadhyaya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73100WB2018PTC226375
- Company No.
226375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Clinimed Lifesciences?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Swati Dasgupta | Director | 31-May-2018 | Current |
Arpan Bhattacharya | Director | 31-May-2018 | Current |
Arindam Ray | Director | 31-May-2018 | Current |
Adreesh Chattopadhyaya | Director | 31-May-2018 | Current |
Priyabrata Das | Director | 31-May-2018 | Current |
Financial Performance of Clinimed Lifesciences.
Clinimed Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 351.12% increase. The company also saw a substantial improvement in profitability, with a 19581.88% increase in profit. The company's net worth Soared by an impressive increase of 1231.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Clinimed Lifesciences?
Unlock access to Clinimed Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Aqb Solutions Private LimitedActive 10 years 4 months
Arindam Ray, Arpan Bhattacharya and 1 more are mutual person
- Oliveqsol Private LimitedActive 2 years 2 months
Arindam Ray, Arpan Bhattacharya and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 16 Dec 2022 | ₹0.99 M | Open |
Hdfc Bank Limited Creation Date: 31 May 2022 | ₹3.72 M | Open |
How Many Employees Work at Clinimed Lifesciences?
Unlock and access historical data on people associated with Clinimed Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinimed Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinimed Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.